- Home
- CURR vs CVRX Comparison
CURR vs CVRX Comparison
Compare CURR & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CURR | CVRX |
|---|---|---|
| Founded | 2013 | 2000 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 224.4M | 221.2M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | CURR | CVRX |
|---|---|---|
| Price | $1.78 | $8.01 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | $3.50 | ★ $13.17 |
| AVG Volume (30 Days) | ★ 229.4K | 161.2K |
| Earning Date | 11-01-2025 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $40,227,053.00 | ★ $55,969,000.00 |
| Revenue This Year | N/A | $11.49 |
| Revenue Next Year | $14.56 | $16.26 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 18.44 |
| 52 Week Low | $0.33 | $4.30 |
| 52 Week High | $7.08 | $18.55 |
Technical Indicators
Market Signals| Indicator | CURR | CVRX |
|---|---|---|
| Relative Strength Index (RSI) | 37.91 | 34.43 |
| Support Level | $1.62 | $8.07 |
| Resistance Level | $1.89 | $8.44 |
| Average True Range (ATR) | 0.22 | 0.58 |
| MACD | -0.08 | -0.10 |
| Stochastic Oscillator | 14.81 | 11.21 |
Price Performance
Historical ComparisonAbout CURR Currenc Group Inc. Ordinary Shares
Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The Company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It generates the majority of its geographic revenue from Malaysia.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.